Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryohei Ohtani

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Neuroimmunology|March 13, 2017
Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activityMayumi Muto, Masahiro Mori, Jia Liu, et al.
Plos One|August 29, 2017
Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorderHiroki Masuda, Shigeki Hirano, Nobuyoshi Takahashi, et al.
Scientific Reports|August 3, 2023
Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controlsHiroki Masuda, Masahiro Mori, Shigeki Hirano, et al.
Journal of the Neurological Sciences|July 18, 2016
Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosisHiroki Masuda, Masahiro Mori, Akiyuki Uzawa, et al.
Journal of Neurology|August 29, 2021
Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disordersHiroki Masuda, Masahiro Mori, Hirotaka Yokouchi, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2010
Multifocal conduction blocks in sarcoid peripheral neuropathySetsu Sawai, Sonoko Misawa, Makoto Kobayashi, et al.
Journal of Neuroimmunology|September 2, 2019
The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgementKazuo Sugimoto, Masahiro Mori, Jia Liu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 15, 2026
Biologic therapy and brain atrophy in neuromyelitis optica: a Japanese-German longitudinal MRI studyHiroki Masuda, Lina Anderhalten, Masahiro Mori, et al.
Journal of Diabetes Investigation|September 16, 2023
Imeglimin-mediated glycemic control in maternally inherited deafness and diabetesRyoichi Ishibashi, Kiichi Hirayama, Suzuka Watanabe, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 21, 2021
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disordersSusanna Asseyer, Hiroki Masuda, Masahiro Mori, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Neuroimmunology|March 13, 2017
Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activityMayumi Muto, Masahiro Mori, Jia Liu, et al.
Plos One|August 29, 2017
Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorderHiroki Masuda, Shigeki Hirano, Nobuyoshi Takahashi, et al.
Scientific Reports|August 3, 2023
Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controlsHiroki Masuda, Masahiro Mori, Shigeki Hirano, et al.
Journal of the Neurological Sciences|July 18, 2016
Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosisHiroki Masuda, Masahiro Mori, Akiyuki Uzawa, et al.
Journal of Neurology|August 29, 2021
Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disordersHiroki Masuda, Masahiro Mori, Hirotaka Yokouchi, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2010
Multifocal conduction blocks in sarcoid peripheral neuropathySetsu Sawai, Sonoko Misawa, Makoto Kobayashi, et al.
Journal of Neuroimmunology|September 2, 2019
The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgementKazuo Sugimoto, Masahiro Mori, Jia Liu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 15, 2026
Biologic therapy and brain atrophy in neuromyelitis optica: a Japanese-German longitudinal MRI studyHiroki Masuda, Lina Anderhalten, Masahiro Mori, et al.
Journal of Diabetes Investigation|September 16, 2023
Imeglimin-mediated glycemic control in maternally inherited deafness and diabetesRyoichi Ishibashi, Kiichi Hirayama, Suzuka Watanabe, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 21, 2021
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disordersSusanna Asseyer, Hiroki Masuda, Masahiro Mori, et al.
Pageof 4